Skip to main content
ZTS
NYSE Life Sciences

FDA Grants Emergency Use Authorization for Zoetis' Simparica Trio Against New World Screwworm

Tom Rudovsky · Reported by BusinessWire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$75.45
Mkt Cap
$31.178B
52W Low
$71.45
52W High
$160.48
52W Position info
5.6% above low
Off High info
53% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

ZTS is trading near its 52-week low of $71.45 (5.6% above the low).

Summary

Zoetis received FDA Emergency Use Authorization for Simparica Trio to treat New World screwworm infestations in dogs and puppies. This is a new regulatory milestone that expands the product's label into an emerging disease area, driven by recent state orders requiring treatment for cross-border animal movement. The EUA provides a first-line treatment option in a public health emergency, potentially boosting near-term demand for the franchise. This follows a difficult Q2 with flat revenue and a 10% guidance cut, so the news offers a positive offset. Watch for any subsequent state or federal procurement orders tied to screwworm response.

At the time of this announcement, ZTS was trading at $75.45 on NYSE in the Life Sciences sector, with a market capitalization of approximately $31.2B. The 52-week trading range was $71.45 to $160.48. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

ZTS - Latest Insights

ZTS
Nov 05, 2026, 1:15 PM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $83.15
Real-time Price: $83.56 info
Change: +$0.415 (+0.50%) info
Market Cap: $33.972B info
ZTS
Nov 05, 2026, 11:40 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $83.48
Real-time Price: $83.56 info
Change: +$0.085 (+0.10%) info
Market Cap: $33.972B info
ZTS
Nov 05, 2026, 7:00 AM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $88.78
Real-time Price: $83.56 info
Change: -$5.22 (-6%) info
Market Cap: $33.972B info
ZTS
Aug 06, 2026, 2:32 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $77.03
Real-time Price: $83.56 info
Change: +$6.53 (+8%) info
Market Cap: $33.972B info
ZTS
Aug 06, 2026, 2:10 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $76.28
Real-time Price: $83.56 info
Change: +$7.28 (+10%) info
Market Cap: $33.972B info